These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15551195)

  • 1. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.
    Kühn KU; Joe AY; Meyer K; Reichmann K; Maier W; Rao ML; Reinhardt MJ; Biersack HJ; Quednow BB
    Pharmacopsychiatry; 2004 Nov; 37(6):286-91. PubMed ID: 15551195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
    Devous MD; Trivedi MH; Rush AJ
    J Nucl Med; 2001 Apr; 42(4):535-42. PubMed ID: 11337538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
    Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
    Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.
    Okada M; Northup JK; Ozaki N; Russell JT; Linnoila M; Goldman D
    Mol Psychiatry; 2004 Jan; 9(1):55-64. PubMed ID: 14699441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.
    Fentress HM; Grinde E; Mazurkiewicz JE; Backstrom JR; Herrick-Davis K; Sanders-Bush E
    Pharmacogenomics J; 2005; 5(4):244-54. PubMed ID: 15912142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract.
    Krishnakumar A; Abraham PM; Paul J; Paulose CS
    J Neurol Sci; 2009 Sep; 284(1-2):124-8. PubMed ID: 19439326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms.
    Racchi M; Leone M; Porrello E; Rigamonti A; Govoni S; Sironi M; Montomoli C; Bussone G
    Headache; 2004 Apr; 44(4):311-7. PubMed ID: 15109354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study.
    Praschak-Rieder N; Willeit M; Zill P; Winkler D; Thierry N; Konstantinidis A; Masellis M; Basile VS; Bondy B; Ackenheil M; Neumeister A; Kaplan AS; Kennedy JL; Kasper S; Levitan R
    J Psychiatr Res; 2005 Nov; 39(6):561-7. PubMed ID: 16157158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
    Nonogaki K; Ohba Y; Sumii M; Oka Y
    Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C).
    Lappalainen J; Zhang L; Dean M; Oz M; Ozaki N; Yu DH; Virkkunen M; Weight F; Linnoila M; Goldman D
    Genomics; 1995 May; 27(2):274-9. PubMed ID: 7557992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice.
    Stiedl O; Misane I; Koch M; Pattij T; Meyer M; Ogren SO
    Neuropharmacology; 2007 Mar; 52(3):949-57. PubMed ID: 17141810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice.
    Somerville EM; Horwood JM; Lee MD; Kennett GA; Clifton PG
    Eur J Neurosci; 2007 May; 25(10):3115-24. PubMed ID: 17561825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
    Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.
    Hayashi A; Suzuki M; Sasamata M; Miyata K
    J Pharm Pharmacol; 2004 Dec; 56(12):1551-6. PubMed ID: 15563762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
    Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
    J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.